Publications by authors named "Emilio Ruiz"

Claim this Profile
T
The CNIC-polypill (acetylsalicylic acid, atorvastatin, and ramipril), an effective and cost-saving secondary prevention strategy compared with other therapeutic options in patients with ischaemic heart disease.
Regina Dalmau, Alberto Cordero, Luís Masana, Emilio Ruiz, Antoni Sicras-Mainar

Eur Heart J Open· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study.
Agustín Sancho-Saldaña, Anna Gil-Sánchez, Cristina González-Mingot, Silvia Peralta, Maria Jose Solana, Emilio Ruiz

J Clin Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial.
José M Mostaza, Carmen Suárez-Fernández, Juan Cosín-Sales, Ricardo Gómez-Huelgas, Carlos Brotons, Emilio Ruiz

BMC Cardiovasc Disord· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CNIC-Polypill reduces recurrent major cardiovascular events in real-life secondary prevention patients in Spain: The NEPTUNO study.
José R González-Juanatey, Alberto Cordero, José Mª Castellano, Luis Masana, Regina Dalmau, Emilio Ruiz

Int J Cardiol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations and Guidance for the Structure, Organisation, and Operation of Cardiometabolic Prevention Units: A Consensus Statement of the Inter-American Society of Cardiology.
Carlos I Ponte-Negretti, Fernando Stuardo Wyss, Daniel Piskorz, Álvaro Sosa Liprandi, Alberto Lorenzatti, Emilio Ruiz

Glob Heart· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CNIC-polypill improves atherogenic dyslipidemia markers in patients at high risk or with cardiovascular disease: Results from a real-world setting in Mexico.
Enrique Gómez-Álvarez, Juan Verdejo, Salvador Ocampo, Carlos I Ponte-Negretti, Emilio Ruíz

Int J Cardiol Heart Vasc· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reaching blood pressure guideline targets with the CNIC polypill in patients with a previous cardiovascular event in Mexico: a analysis of the SORS study.
Enrique Gómez-Álvarez, Juan Verdejo, Salvador Ocampo, Emilio Ruiz, Marco A Martinez-Rios

Future Cardiol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Effectiveness of the Cardiovascular Polypill in a Real-Life Setting in Patients with Cardiovascular Risk: The SORS Study.
Jose M Castellano, Juan Verdejo, Salvador Ocampo, Marco Martinez Rios, Enrique Gómez-Álvarez, Emilio Ruiz

Arch Med Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal pharmacological treatment and adherence to medication in secondary prevention of cardiovascular events in Spain: Results from the CAPS study.
Alberto Cordero, Luis Rodriguez Padial, Alberto Batalla, Luis López Barreiro, Francisco Torres Calvo, Emilio Ruiz

Cardiovasc Ther· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Cost-effectiveness of rosuvastatin versus simvastatin, atorvastatin and pitavastatin in patients with high and very high cardiovascular risk in Spain].
Juan Cosin Sales, Francisco José Fuentes Jiménez, Teresa Mantilla Morató, Emilio Ruiz, Virginia Becerra

Clin Investig Arterioscler· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Patient's care and management of dyslipidemia at discharge after an acute coronary syndrome in the clinical practice in Spain: The SINCOPA study].
Nekane Murga, Emilio Ruiz, Vicente Pascual,

Clin Investig Arterioscler· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Degree of Lipid Control in Patients With Coronary Heart Disease and Measures Adopted by Physicians. REPAR Study.
Enrique Galve, Alberto Cordero, Angel Cequier, Emilio Ruiz, José Ramón González-Juanatey

Rev Esp Cardiol (Engl Ed)· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in Risk Factors and Treatments in Patients With Stable Ischemic Heart Disease Seen at Cardiology Clinics Between 2006 and 2014.
Alberto Cordero, Enrique Galve, Vicente Bertomeu-Martínez, Héctor Bueno, Lorenzo Fácila, Emilio Ruiz

Rev Esp Cardiol (Engl Ed)· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception.
Nuria Plana, Daiana Ibarretxe, Anna Cabré, Emilio Ruiz, Lluis Masana

Clin Investig Arterioscler· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental Nephrectomies Using a Novel Telesurgical System: (The Telelap ALF-X)-A Pilot Study.
Cristina Falavolti, Stefano Gidaro, Emilio Ruiz, Emanuela Altobelli, Michael Stark

Surg Technol Int· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mining Natural-Products Screening Data for Target-Class Chemical Motifs.
Isabel Coma, Deepak Bandyopadhyay, Emilio Diez, Emilio Alvarez Ruiz, Maria Teresa de los Frailes

J Biomol Screen· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vesicourethral anastomosis using a novel telesurgical system with haptic sensation, the Telelap Alf-X: a pilot study.
Stefano Gidaro, Emanuela Altobelli, Cristina Falavolti, Alfredo Maria Bove, Emilio Morales Ruiz

Surg Technol Int· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between serum levels of triglycerides and vascular inflammation, measured as COX-2, in arteries from diabetic patients: a translational study.
Antonio Gordillo-Moscoso, Emilio Ruiz, Manuel Carnero, Fernando Reguillo, Enrique Rodriguez

Lipids Health Dis· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telelap Alf-X: a novel telesurgical system for the 21st century.
Stefano Gidaro, Maurizio Buscarini, Emilio Ruiz, Michael Stark, Anna Labruzzo

Surg Technol Int· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of TGF-beta1 and MAP kinases in the antiproliferative effect of aspirin in human vascular smooth muscle cells.
Santiago Redondo, Emilio Ruiz, Antonio Gordillo-Moscoso, Jorge Navarro-Dorado, Marta Ramajo

PLoS One· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EPC adhesion to arteries from diabetic and non-diabetic patients: effect of pioglitazone.
Emilio Ruiz, Santiago Redondo, Antonio Gordillo-Moscoso, Enrique Rodriguez, Fernando Reguillo

Front Biosci (Landmark Ed)· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-reproducible flow cytometric endothelial progenitor cell determination in human peripheral blood as CD34+/CD144+/CD3- lymphocyte sub-population.
Santiago Redondo, Mihail Hristov, Antonio A Gordillo-Moscoso, Emilio Ruiz, Christian Weber

J Immunol Methods· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of intracellular angiotensin II in vascular smooth muscle cell apoptosis: inhibition by the angiotensin AT1 receptor antagonist irbesartan.
Emilio Ruiz, Santiago Redondo, Eugenia Padilla, Antonio Gordillo-Moscoso, Mercedes Salaices

Eur J Pharmacol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pioglitazone induces apoptosis in human vascular smooth muscle cells from diabetic patients involving the transforming growth factor-beta/activin receptor-like kinase-4/5/7/Smad2 signaling pathway.
Emilio Ruiz, Santiago Redondo, Antonio Gordillo-Moscoso, Teresa Tejerina

J Pharmacol Exp Ther· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations in the choroid in hypercholesterolemic rabbits: reversibility after normalization of cholesterol levels.
Juan J Salazar, Ana I Ramírez, Rosa de Hoz, Blanca Rojas, Emilio Ruiz

Exp Eye Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis